Breakthrough Science
We relentlessly pursue bold science to translate genetic discoveries into new medicines that advance the future of human health.
GACI Global Co-President Christine O’Brien and her children, Callum and Nora, are navigating life with ENPP1 deficiency and advocating for a brighter future.
After originally pursuing music, a college assignment opened Andrew’s mind to science and led to his fascination with using biology to advance human health.
Donnie has spent more than a decade at BioMarin contributing to research that is helping redefine care for people with rare skeletal and bone conditions.
We relentlessly pursue bold science to translate genetic discoveries into new medicines that advance the future of human health.
We listen to and learn from patient communities to collaborate on solutions with the potential to help improve care.
Our talented and dedicated people represent the best the biotech industry has to offer and have helped shape a culture focused on working together to deliver for the patients we serve.
Founded in 1997, we have a proven track record of innovation, with eight commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin seeks to unleash the full potential of genetic science by pursuing category-defining medicines that have a profound impact on patients.
January 29, 2026
January 26, 2026
January 12, 2026
January 8, 2026
January 8, 2026
Come work with us. Search our global career opportunities to learn how you can make your mark.